Rob MacNaughton has been named new chief executive officer of Calibrate, a clinician-guided, value-based obesity treatment program, and one of his first missions will be to solidify a relationship with Optum Rx as a strategic partner during the company’s enterprise-first growth phase.
New Calibrate CEO seeks to strengthen partnership with Optum Rx
